Washington Trust Advisors, Inc. Haemonetics Corp Transaction History
Washington Trust Advisors, Inc.
- $1.09 Billion
- Q1 2025
A detailed history of Washington Trust Advisors, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 129 shares of HAE stock, worth $9,242. This represents 0.0% of its overall portfolio holdings.
Number of Shares
129
Previous 102
26.47%
Holding current value
$9,242
Previous $7,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HAE
# of Institutions
351Shares Held
53.3MCall Options Held
417KPut Options Held
314K-
Black Rock Inc. New York, NY5.96MShares$427 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$365 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.35MShares$312 Million0.24% of portfolio
-
Wellington Management Group LLP Boston, MA2.62MShares$188 Million0.03% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.2MShares$157 Million0.09% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.68B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...